{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:50Z","timestamp":1791421610676,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ophtha.2010.01.028","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T02:10:34Z","timestamp":1274062234000},"page":"1831-1838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Intravitreal Clindamycin and Dexamethasone for Zone 1 Toxoplasmic Retinochoroiditis at Twenty-four Months"],"prefix":"10.1016","volume":"117","author":[{"given":"Andr\u00e9s F.","family":"Lasave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00edaz-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Rubens","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fernando","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.01.028_bib1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"15","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2010.01.028_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08820530500231961","article-title":"Toxoplasmosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(14)73706-7","article-title":"Current practices in the management of ocular toxoplasmosis","volume":"111","author":"Engstrom","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(92)31873-1","article-title":"Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis","volume":"99","author":"Opremcak","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.01.028_bib5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.82.11.1306","article-title":"Azithromycin for ocular toxoplasmosis","volume":"82","author":"Rothova","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","article-title":"Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients","volume":"106","author":"Pearson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.01.028_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02306491","article-title":"Therapy of ocular toxoplasmosis","volume":"13","author":"Rothova","year":"1989","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib9","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review","volume":"30","author":"Iaccheri","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2010.01.028_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archopht.1976.03910030120009","article-title":"Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy","volume":"94","author":"Nicholson","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bjo.82.8.858","article-title":"Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis","volume":"82","author":"Bosch-Driessen","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000310680","article-title":"Laser photocoagulation around the foci of toxoplasma retinochoroiditis: a descriptive statistical analysis of 35 patients with long-term follow-up","volume":"210","author":"Desmettre","year":"1996","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2010.01.028_bib14","first-page":"853","article-title":"Cryotreatment of toxoplasmosis retinochoroiditis","volume":"7","author":"Jacklin","year":"1975","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib15","first-page":"303","article-title":"Iatrogenic neovascularization: value of a treatment by laser photocoagulation on foci of toxoplasmic choroiditis [in French]?","volume":"87","author":"Vallat","year":"1987","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.ophtha.2010.01.028_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18773\/austprescr.2002.075","article-title":"Treatment of ocular toxoplasmosis","volume":"25","author":"Ng","year":"2002","journal-title":"Aust Prescriber"},{"key":"10.1016\/j.ophtha.2010.01.028_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00171025","article-title":"Toxicity of high-dose intravitreal dexamethasone","volume":"15","author":"Nabih","year":"1991","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02028207","article-title":"Evaluation of liposome-encapsulated clindamycin in Staphylococcus aureus endophthalmitis","volume":"13","author":"Rao","year":"1989","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","article-title":"Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis","volume":"32","author":"Kishore","year":"2001","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.ophtha.2010.01.028_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006129422690","article-title":"Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine","volume":"22","author":"Martinez","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of standardized system for the assessment of disease outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/IAE.0b013e31804b3f0d","article-title":"Intravitreal clindamycin for toxoplasmic retinochoroiditis","volume":"27","author":"Sobrin","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2010.01.028_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10792-008-9192-8","article-title":"Toxoplasma gondii: an atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin","volume":"29","author":"Wong","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archopht.1976.03910030093001","article-title":"Dangers of steroid treatment in toxoplasmosis: periocular injections and systemic therapy","volume":"94","author":"O'Connor","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.01.028_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:59:34Z","timestamp":1758981574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0161642010000564"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Clindamycin and Dexamethasone for Zone 1 Toxoplasmic Retinochoroiditis at Twenty-four Months","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}